You are here: Industry Insights > RNA

News List

SMi Group announces the 10th Annual RNA Therapeutics Conference worldpharmanews
October 12, 2018
Undoubtedly, the field of RNA therapeutics is currently undergoing a major expansion, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the contin
Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M fiercevaccines
July 23, 2018
Moving to expand its vaccine pipeline after some slip-ups last year, Sanofi is betting on Translate Bio's mRNA platform in up to five undisclosed infectious disease targets.
Moderna opens $110M manufacturing site for its mRNA program fiercevaccines
July 23, 2018
Moderna Therapeutics, which is pushing a pipeline of mRNA candidates into phase 2 trials, now has a manufacturing plant ready to advance its highly anticipated program.
Some existing anti-cancer drugs may act in part by targeting RNA worldpharmanews
July 05, 2018
Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part
RNA biotech Arcturus backs onto Nasdaq in Alcobra deal fiercebiotech
September 29, 2017
The deal will give Arcturus a route to public investors at a time when interest in RNA therapies is flying high on the back of Alnylam’s phase 3 success.
Cells programmed like computers to fight disease worldpharmanews
September 19, 2017
Cells can be programmed like a computer to fight cancer, influenza, and other serious conditions - thanks to a breakthrough in synthetic biology by the University of Warwick.
RNA-targeting CRISPR could yield treatments for Huntington's, ALS fiercebiotech
August 11, 2017
UC San Diego researchers are using CRISPR-Cas9 to target RNA, which could lead treatments for genetic diseases that have no cure.

Previous page 1 2 3 4 Next page